Nephros (NEPH)

• Market cap: $15.6M
• 1 day: -0.67%
• 5 days: -2.63%
• 1 month: -5.13%
• 3 months: -17.32%
• 6 months: -28.50%
• Year to date: -56.85%
• 1 year: -60.00%
• 5 years: -85.05%
• 10 years: -77.34%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Employees: 31

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.39% less ownership

Funds ownership: 41.04% [Q2] → 40.65% (-0.39%) [Q3]

6% less funds holding

Funds holding: 18 [Q2] → 17 (-1) [Q3]

20% less capital invested

Capital invested by funds: $9.17M [Q2] → $7.33M (-$1.84M) [Q3]

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $5 238% upside
• Avg. target: $5 238% upside
• High target: $5 238% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Robert Wasserman 56% 1-year accuracy 28 / 50 met price target

238% upside $5

Speculative Buy Reiterated

12 Nov 2024